T-group (topology)
7559.1.1 Ribosomal protein L4
Ligands and drugs
3,403
Member domains
1,386
with ligand contacts (≤ 4 Å)
40.7% of members
620
with DrugDomain annotations
18.2% of members
37
with a DrugBank compound
1.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7559.1.1 belongs to X-group 7559 Ribosomal protein L4, which binds 5.2 ligand superclasses per 20 proteins, narrower than 80% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00125 | ARG | Arginine | 16 |
| DB03566 | SPD | Spermidine | 3 |
| DB00954 | DI0 | Dirithromycin | 2 |
| DB00207 | ZIT | Azithromycin | 1 |
| DB00479 | AKN | Amikacin | 1 |
| DB04626 | AM2 | Apramycin | 1 |
| DB06145 | SPR | Spiramycin | 1 |
| DB11638 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 1,365 |
| OHX | osmium (III) hexammine | 76 |
| Kmetal | POTASSIUM ION | 68 |
| NAmetal | SODIUM ION | 66 |
| SPD | SPERMIDINE | 52 |
| ARG | ARGININE | 21 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 9 |
| MNmetal | MANGANESE (II) ION | 6 |
| PAR | PAROMOMYCIN | 6 |
| UNX | UNKNOWN ATOM OR ION | 6 |
| PUT | 1,4-DIAMINOBUTANE | 5 |
| CL | CHLORIDE ION | 3 |
| SPM | SPERMINE | 3 |
| SRmetal | STRONTIUM ION | 3 |
| LUJ | (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2,4-dideoxy-4-propyl-alpha-D-glucopyranoside | 2 |
| SJE | (2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-12-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-((S)-1-(((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)-10-(((2S,3R,4R,6R)-3-hydroxy-4-(methoxyamino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-7-(((2-((2-nitrophenyl)sulfonamido)ethyl)carbamoyl)oxy)-6,14-dioxooxacyclotetradecan-4-yl 3-methylbutanoate | 2 |
| SJH | (2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-12-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-((S)-1-(((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)-10-(((2S,3R,6R,E)-3-hydroxy-4-(methoxyimino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-7-(((2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)carbamoyl)oxy)-6,14-dioxooxacyclotetradecan-4-yl 3-methylbutanoate | 2 |
| WDP | Sequanamycin 9 | 2 |
| 84G | Arbekacin | 1 |
| AKN | (2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide | 1 |